相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cost-effectiveness of rosuvastatin in the prevention of ischemic heart disease in Portugal
Carlos Gouveia Pinto et al.
VALUE IN HEALTH (2008)
Plant stanol esters are potentially cost-effective in the prevention of coronary heart disease in men: Bayesian modelling approach
Janne A. Martikainen et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2007)
Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from randomised trial of 20 536 people
Borislava Mihaylova et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis
Daniel M. Huse et al.
CLINICAL THERAPEUTICS (2006)
An interpretive history of the cholesterol controversy, part V: The discovery of the statins and the end of the controversy
Daniel Steinberg
JOURNAL OF LIPID RESEARCH (2006)
Economic burden of cardiovascular diseases in the enlarged European Union
Jose Leal et al.
EUROPEAN HEART JOURNAL (2006)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention
S Perreault et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
JC LaRosa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Predicted and observed cardiovascular disease in South Asians: Application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data
R Bhopal et al.
JOURNAL OF PUBLIC HEALTH (2005)
Pharmacoeconomic impact of non-compliance with statins
AM Peterson et al.
PHARMACOECONOMICS (2005)
Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis
N Devlin et al.
HEALTH ECONOMICS (2004)
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvalstaltin, and pravastatin across doses (STELLAR* trial)
PH Jones et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis
MR Law et al.
BRITISH MEDICAL JOURNAL (2003)
Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project
RM Conroy et al.
EUROPEAN HEART JOURNAL (2003)
Framingham risk function overestimates risk of coronary heart disease in men and women from Germany -: results from the MONICA Augsburg and the PROCAM cohorts
HW Hense et al.
EUROPEAN HEART JOURNAL (2003)
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
HM Lakka et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study
TF Thomsen et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
The 15D instrument of health-related quality of life: properties and applications
H Sintonen
ANNALS OF MEDICINE (2001)
分享论文
